课题基金 / 基金详情

After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada

After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后：衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
批准号：
469805
负责人：
Klein Marina B
金额：
$115.64万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469805&lang=en
关键词：
Access To Care Co-Infection Cure Direct Acting Antivirals Fibrosis Progression Health Outcomes Hepatitis C Virus Hiv Prospective Cohort Study Re-Infection

项目摘要

项目成果

Klein Marina B的其他基金

相似基金

相关文献

中文摘要
翻译
2015年，高效直接作用抗病毒药物（DAAs）的广泛使用开启了丙型肝炎病毒（HCV）的“包治百病”时代。有了DAAs，就有机会解决导致人们生病和死亡的最重要原因之一
英文摘要
In 2015, the wide availability of highly effective direct-acting antivirals (DAAs) ushered in a "treat all" era for hepatitis C virus (HCV). With DAAs came the opportunity to address one of the most significant causes of illness and death in people living
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
26th International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
5th International HIV/Viral Hepatitis Co-infection IAS Satellite Meeting
23rd International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
海外基金